Skip to main content
Sansure Biotech Inc. logo

Sansure Biotech Inc. — Investor Relations & Filings

Ticker · 688289 ISIN · CNE1000043J1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 870 across all filing types
Latest filing 2025-07-21 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688289

About Sansure Biotech Inc.

https://www.sansureglobal.com/

Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.

Recent filings

Filing Released Lang Actions
圣湘生物科技股份有限公司2025年第三次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as the "2025 Third Extraordinary General Meeting (EGM) Meeting Materials" of 圣湘生物科技股份有限公司. It contains detailed meeting instructions, agenda, and multiple proposals for shareholder approval, including stock incentive plans, governance changes, and board elections. The content is clearly materials prepared for a shareholders' meeting, including proposals to be voted on, meeting procedures, and legal compliance notes. There is no financial statement or earnings data, nor is it a transcript or announcement of results. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. The document length is substantial (9544 characters), consistent with detailed meeting materials rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2025-07-21 Chinese
湖南启元律师事务所关于圣湘生物科技股份有限公司2025年限制性股票激励计划（草案）的法律意见书
Regulatory Filings
2025-07-11 Chinese
圣湘生物科技股份有限公司关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and nomination of the company's board of directors, detailing the candidates for the new board, their qualifications, and compliance with relevant laws and regulations. It includes information about the board election process, candidate biographies, and legal compliance statements. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG).
2025-07-11 Chinese
圣湘生物科技股份有限公司独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the rules, responsibilities, nomination, election, and legal liabilities of independent directors in the company. The content is focused on governance practices, board structure, and the duties of independent directors rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial data, earnings, voting results, or regulatory filings. The document is a governance framework document outlining internal rules and practices for independent directors. Therefore, it fits best under the category of Governance Information (CGR). The document length (8467 characters) supports it being a full policy document rather than a brief announcement or certification.
2025-07-11 Chinese
圣湘生物科技股份有限公司股东会议事规则
Governance Information Classification · 95% confidence The document is titled "股东会议事规则" which translates to "Shareholders Meeting Rules". It contains detailed procedural rules for convening and conducting shareholders meetings, including the rights and responsibilities of shareholders, board of directors, and committees. It references relevant laws and regulations governing shareholder meetings and corporate governance. The content is regulatory and governance-related, focusing on internal rules and procedures rather than financial results, voting outcomes, or announcements. It is not a report of financial performance, voting results, or a meeting presentation. Therefore, the document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (7558 characters) and detailed content support this classification with high confidence.
2025-07-11 Chinese
圣湘生物科技股份有限公司累积投票制度
Governance Information Classification · 95% confidence The document is a detailed description of the cumulative voting system for the election of directors at 圣湘生物科技股份有限公司. It outlines the rules, procedures, and principles for nominating and electing board members, including voting rights and election rounds. There is no financial data, no mention of a specific report or financial period, and no indication that this is an announcement or summary of a meeting. The content is focused on governance practices related to board elections, which fits the category of Governance Information (CGR). The document length is 2095 characters, which is relatively short but contains substantive governance content rather than a mere announcement or notice. Therefore, the appropriate classification is Governance Information (CGR).
2025-07-11 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.